TriSalus Life Sciences, Inc.
TLSI · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$30 | -$59 | -$47 | -$29 |
| Dep. & Amort. | $1 | $1 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $5 | $1 | $0 | $0 |
| Change in WC | -$10 | $1 | $2 | -$0 |
| Other Non-Cash | -$7 | $6 | $12 | $6 |
| Operating Cash Flow | -$41 | -$51 | -$32 | -$23 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$1 | -$1 | -$1 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | -$1 | -$1 | -$1 |
| Investing Cash Flow | -$0 | -$2 | -$2 | -$2 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $25 | -$0 | -$0 | -$1 |
| Stock Issued | $16 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$3 | $55 | $14 | $52 |
| Financing Cash Flow | $38 | $55 | $13 | $51 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$3 | $2 | -$21 | $26 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $12 | $10 | $30 | $4 |
| End Cash | $9 | $12 | $10 | $30 |
| Free Cash Flow | -$41 | -$51 | -$33 | -$24 |